Study of BI 1291583 for people with bronchiectasis
Part of Lungs & breathing clinical trials.
This trial tests whether a new medication, BI 1291583, can help people with bronchiectasis reduce lung infections and symptoms. You may join if you have had at least one or two lung flare-ups in the past year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 years or older (if under 18, must weigh at least 35 kg)
- You have a doctor-confirmed diagnosis of bronchiectasis based on a CT scan
- You have had at least 1 or 2 lung infections requiring antibiotics in the last year (depending on your symptom burden)
- You can produce sputum (phlegm) for testing
- You are not currently being treated for tuberculosis, aspergillosis, or a new immune deficiency
- You do not have severe liver or kidney disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a new drug, GSK3862995B, is safe and effective for adults with bronchiectasis. It might help reduce lung infections and improve symptoms.
This trial tests an inhaled medication for people with bronchiectasis, a lung condition causing chronic cough and mucus. It first checks safety in healthy volunteers, then studies how the drug works in people with bronchiectasis.
This study looks at how bacteria live in the lungs of people with bronchiectasis and how they may adapt over time. It may help researchers understand why infections keep coming back and how to better manage chronic lung colonization.
This trial tests two different antibiotic treatments for adults with bronchiectasis who have a new or recent infection with Pseudomonas aeruginosa (PA) bacteria in their airways. The goal is to see which regimen works better to clear the infection early.
This trial tests a home-use device called BiWaze Clear, which helps clear mucus from your lungs. It is for people with bronchiectasis (including those with cystic fibrosis) who have had recent lung infections and can use the device at home.
This trial tests the LibAirty system, a device that helps clear mucus from your lungs, in people with bronchiectasis. Participants use the device at home to see how well it works in daily life.
Hear when a new Bronchiectasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.